CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 732 enrolled
Drug / intervention
Tampon BR +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05553600
NCT05553600N/ACompleted
CompareCT.gov

An Open-Label Clinical Validation Study of an Applicator Tampon

Kimberly-Clark Corporation·interventional·Posted Sep 23, 2022·Updated Jan 17, 2024

In Brief

A clinical study evaluating Tampon BR, Tampon CR, and 2 other interventions for Menstruation. Completed, enrolled 732 participants across 9 sites.

Detailed Summary

This prospective multi-center, open-label, randomized, cross-over study is designed to validate the user needs of a tampon design. The hypothesis is that user needs are met.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMenstruation
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 23, 2022
Enrollment StartOct 21, 2022
Primary CompletionMay 5, 2023
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.8 years ago

Interventions

Tampon BRdevice

Modified Regular Absorbency Tampons

Tampon CRdevice

Reference Regular Absorbency Tampons

Tampon BSdevice

Modified Super Absorbency Tampons

Tampon CSdevice

Reference Super Absorbency Tampons